Click HERE to view selected presentations

Click here to download a PDF of this program

Click on a name or session to view additional information

7:30 AM Badge Pick-Up
8:30 AM Welcome
Harold H. Shlevin, PhD; President and Chief Executive Officer, Tikvah Therapeutics, Inc.
8:40 AM Speaker Introduction
Jack Capers; King & Spalding - Champion Sponsor of Georgia Bio

State of the Life Sciences Industry in Georgia
Russell M. Medford, MD, PhD; President and Chief Executive Officer, AtheroGenics, Inc. and Chairman, Georgia Bio
9:00 AM Speaker Introduction
Bruce C. Robertson, PhD; Managing Director, H.I.G. Ventures

Innovation through Integration: Fostering Continued Pipeline Growth
David M. Mott; President and Chief Executive Officer, MedImmune
9:30 AM Speaker Introduction
Walt Linscott; Thompson Hine - Champion Sponsor of Georgia Bio

The Next Wave of Beverage Innovation
Rhona S. Applebaum, PhD; Chief Regulatory Officer, The Coca-Cola Company
10:00 AM Speaker Introduction
Michelle Williams; Alston Bird - Champion Sponsor of Georgia Bio

Elements for Success for Emerging Medical Device Companies
Howard D. Palefsky; General Partner/Managing Member, Montreux Equity Partners
10:30 AM Speaker Introduction
Robert T. McNally, PhD; Chief Executive Officer, Cell Dynamics, LLC
TIGON Nanostrategies
Matt Rhyner; PhD Candidate, Biomedical Engineering, Georgia Tech (Dissertation is the basis for the technology)
Tom Rafferty, JD; Emory (Alumni), Weinstock and Scavo
Meadow Gerard, JD; Emory (Alumni), Patton Boggs
David Madden, MBA; Georgia Tech (Alumni), ContainerExchanger
10:45 AM Exhibit and Poster Viewing / Refreshments
11:15 AM MORNING CONCURRENT FOCUS SESSION
1a. The Next Wave of Innovation In Agricultural Sciences
Clifton A. Baile, PhD - Moderator; Georgia Research Alliance Eminent Scholar in Agricultural Biotechnology and Distinguished Professor of Animal Science and Foods and Nutrition, The University of Georgia
Scott E. Deeter; President and Chief Executive Officer, Ventria Bioscience
Stephen R. Padgette, PhD; Vice President Biotechnology, Monsanto Corporation
Edwin Quattlebaum, PhD; Co-Chairman, President and Chief Executive Officer, MetaMorphix, Inc.
1b. Georgia is the Epicenter of Global Healthcare
Todd T. Sherer, PhD - Moderator; Associate Vice President for Research and Director, Office of Technology Transfer, Emory University
Vincent C. Bond, PhD; Associate Professor and HIV-AIDS Researcher, Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine
Daniel G. Colley, PhD; Director, Center for Tropical and Emerging Global Diseases, Professor of Microbiology, The University of Georgia
Stephen DeCherney, MD, MPH; Chief Innovation Officer, Quintiles Transnational
Dennis C. Liotta, PhD; Samuel Candler Dobbs Professor of Chemistry, Emory University
Ernesto Ruiz-Tiben, PhD; Director, Dracunculiasis (Guinea worm disease) Eradication Program, The Carter Center
1c. The Next Generation of Georgia's Life Science Companies
Bruce C. Robertson, PhD - Moderator; Managing Director, H.I.G. Ventures
Russell H. Plumb; President and Chief Executive Officer, Inhibitex, Inc.
Harold H. Shlevin, PhD; President and Chief Executive Officer, Tikvah Therapeutics, Inc.
Tony Shuker; President and Chief Executive Officer, Metastatix, Inc.
Jay Yadav MD, FACC; Chairman and Chief Executive Officer, CardioMEMS, Inc.
12:30 AM LUNCH
1:30 PM Speaker Introduction
Phillip Street; Kilpatrick Stockton - Champion Sponsor of Georgia Bio

Agriculture: A Growing Opportunity
Jerry A. Steiner; Executive Vice President Commercial Acceptance, Monsanto Corporation
2:00 PM AFTERNOON CONCURRENT FOCUS SESSIONS
2a. Medical Device Innovation in Georgia
Howard D. Palefsky - Moderator; General Partner/Managing Member, Montreux Equity Partners
Timothy J. Patrick - Moderator; President and Chief Executive Officer, Carticept Medical, Inc.
Jakob Vinten-Johansen, PhD - Moderator; Professor, Cardiothoracic Research Laboratory, Carlyle Fraser Heart Center, Emory University and Founder, Reperfusion Therapeutics
Lawrence Catchpole; President and Chief Executive Officer, Detect
Henry Grage; President, Reperfusion Therapeutics, Inc.
Bruce W. Smith; Executive Vice President Strategy and Business Development, Theragenics Corporation
Eric Tomlinson, DSc, PhD; President and Chief Executive Officer, Altea Therapeutics
Thomas A. Vassiliades Jr., MD; Associate Professor of Surgery, Division of Cardiothoracic Surgery, Emory University School of Medicine
2b. Partnering for Success
John P. Richard - Moderator; Managing Director, Georgia Venture Partners
BJ Bormann-Kennedy, PhD; Vice President, Strategic Alliances, Pfizer R&D
Kris Ford; Vice President, Corporate Strategies and Business Development, UCB
Charles Montgomery; Senior Vice President of Business Development and Alliance Management, Atherogenics
2c. BioEnergy to Power Our State
Robert M. Nerem, PhD - Moderator; Parker H. Petit Professor and Director, IBB, Georgia Institute of Technology
William S. Bulpitt, PE; Strategic Energy Initiative, Georgia Institute of Technology
Neal Gutterson, PhD; President and Chief Executive Officer, Mendel Biotechnology
Roger H. Reisert; President and Chief Executive Officer, C2 Biofuels, LLC
Edward T. Shonsey; Chief Executive Officer, Ethanol Energy
3:15 PM Networking Break / Science Posters / Exhibits
3:45 PM RESEARCH ADVANCES IN GEORGIA: FOCUS ON CANCER
Margaret K. Offermann, MD, PhD - Moderator; Deputy National Vice President for Research, American Cancer Society
William J. Todd; President and Chief Executive Officer, Georgia Cancer Coalition
Ravi V. Bellamkonda, PhD; Georgia Cancer Coalition Distinguished Scholar and Professor of Biomedical Engineering, Wallace H Coulter Department of Biomedical Engineering, Georgia Institute of Technology/Emory University
Brian Leyland-Jones, MD, PhD; Georgia Research Alliance Eminent Scholar and Director, Winship Cancer Institute, Emory University
Michael J. Thun, MD; Vice President of Epidemiology and Surveillance Research, American Cancer Society
5:15 PM Speaker Introduction
Robert T. McNally, PhD; Chief Executive Officer, Cell Dynamics, LLC

ViraTag LLC
Nimisha Gupta; PhD Candidate Georgia Tech, Biomedical Engineering, Chief Executive Officer (Dissertation is the basis for the technology)
Jim McDonough, JD; Emory University (Alumni), Chief Financial Officer (Finance)
Dev Ghose, JD; Emory University (Alumni), Chief Operations Officer (Operations)
5:30 PM Presentation of Poster Awards
Keith A. Robinson, PhD; Director of Preclinical Sciences, Saint Joseph's Research Institute
5:45 PM Closing Remarks
Harold H. Shlevin, PhD; President and Chief Executive Officer, Tikvah Therapeutics, Inc.
6:00 PM Gala Party at the World of Coca-Cola
The Summit will conclude with a Gala Party, Getting to know our Life Sciences Community, at the NEW World of Coca-Cola